Transmitting information to us by e-mail unilaterally does not establish an attorney-client relationship or impose an obligation on either the law firm or even the receiving lawyer to keep the transmitted information confidential. By clicking "OK", you acknowledge that we have no obligation to maintain the confidentiality of any information you submit to us unless we already represent you or unless we have agreed to receive limited confidential material/information from you as a prospective client. Thus, if you are not a client or someone we have agreed to consider as a prospective client, information you submit to us by e-mail may be disclosed to others or used against you. If you would like to discuss becoming a client, please contact one of our attorneys to arrange for a meeting or telephone conference. If you wish to disclose confidential information to a lawyer in the firm before an attorney-client relationship is established, the protections that the law firm will provide to such information from a prospective client should be discussed before such information is submitted. Thank you for your interest in Goodwin Procter.

main

otherindustries-acs-webinar-non-patent-ip-strategies

Join Goodwin professionals and discover how trade secrets shape chemical research in this ACS webinar—insights, strategies, and real-world cases you can't afford to miss.

ACS Webinar - Protecting the Formula: The Role of Trade Secrets in Chemical Research

Summary

Speakers

Robert Frederickson III

Olivia D. Uitto

Yoko J. Bian, Ph.D.

Related Content

House Passes 10-Year Federal Moratorium on State AI Regulation: Key Implications for Businesses

The Court of Appeals for the Federal Circuit’s In Re Riggs Decision: 35 USC 102(e) Prior Art Requires Written Description Support in Provisional Application for Disclosure Relied On to Reject Claims

The Court of Appeals for the Federal Circuit’s In Re Xencor Decision: Jepson Claims Require Written Description for Their Preambles

Second Circuit Sees Eye to Eye With Warby Parker in Trademark Google Ads Dispute

Four Steps to Maximize the Value of AI Innovation in Medtech

Are AI Inventions Harder to Patent?

FDA Platform Technology Draft Guidance Highlights Utility of Obscure Patent Term Extension Provision

USPTO Issues Further Guidance on AI-Related Patent Eligibility

Chambers USA 2025 Recognizes a Record Number of Goodwin Practices and Lawyers for Exceptional Client Service

Blueprint Medicines To Be Acquired By Sanofi For $9.5 Billion Including Contingent Value Rights

Latest Patent News in Women’s Health (MedCity News)

Goodwin Named to Los Angeles Business Journal’s 2025 List of Largest Law Firms in LA

Goodwin's IP Litigation Team Secures Preliminary Injunction for Canopy Works In Contract and IP Dispute With Former Reseller

Goodwin Welcomes Leading Life Sciences and Intellectual Property Partner William T. Christiansen II Ph.D.

EcoFactor v Google Unlikely to Result in ‘Tectonic Shifts in the Law’ (World IP Review)

Neel Chatterjee and Brett Schuman Recognized by Daily Journal’s Top IP Lawyers 2025

Intellectual Property

Intellectual Property Litigation

Trademarks

Copyrights

Trade Secrets, Employee Mobility & Non-Competes